Amended and Restated Severance and Change of Control AgreementControl Agreement • March 2nd, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of October 3, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Sean McCarthy, D. Phil. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of April 1, 2015 by and between the Company and Employee, as amended (the “Prior Agreement”).
Severance and Change of Control AgreementControl Agreement • March 2nd, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Michael Kavanaugh, Senior Vice President, Chief Scientific Officer (“Employee”).
